Environmental photodegradation of mefenamic acid

被引:83
|
作者
Werner, JJ
McNeill, K
Arnold, WA
机构
[1] Univ Minnesota, Dept Civil Engn, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Water Resources Sci Program, St Paul, MN 55108 USA
[3] Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA
关键词
photolysis; pharmaceutical; triplet; quantum yield; dissolved organic matter;
D O I
10.1016/j.chemosphere.2004.10.004
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Pharmaceuticals and personal care products are an emerging class of environmental pollutants. Photolysis is expected to be a major loss process for many of these compounds in surface waters, including the common non-steroidal anti-inflammatory drug mefenamic acid. The direct photolysis solar quantum yield of mefenamic acid was observed to be 1.5 +/- 0.3 x 10(-4). Significant photosensitization was observed in solutions of Suwanee River fulvic acid and Mississippi River water, as well as for the model photosensitization compounds 3'-methoxyacetophenone, 2-acetonaphthone and perinaphthenone. Quenching, sparging and light-filtering experiments suggested a direct reaction of mefenamic acid with excited triplet-state dissolved organic matter as the major photosensitization process. The persistence of the model photosensitizer suggests that the photosensitization by perinaphthenone occurs either by triplet-energy transfer or an electron transfer followed by rapid regeneration of the sensitizer. Due to its low quantum yield, the loss of mefenamic acid in sunlit natural waters is expected to depend on both direct and indirect photodegradation processes. (c) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1339 / 1346
页数:8
相关论文
共 50 条
  • [41] Some physicochemical properties of mefenamic acid
    Adam, A
    Schrimpl, L
    Schmidt, PC
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2000, 26 (05) : 477 - 487
  • [42] Evaluation of mefenamic acid mutual prodrugs
    Kamal Shah
    Sushant K. Shrivastava
    Pradeep Mishra
    Medicinal Chemistry Research, 2013, 22 : 70 - 77
  • [43] HAEMOLYTIC ANAEMIA ASSOCIATED WITH MEFENAMIC ACID
    ROBERTSON, JH
    KENNEDY, CC
    HILL, CM
    IRISH JOURNAL OF MEDICAL SCIENCE, 1971, 140 (05) : 226 - +
  • [44] Enhanced photocatalytic activity of supported CuO-ZnO semiconductors towards the photodegradation of mefenamic acid aqueous solution as a semi real sample
    Shirzadi, Arezoo
    Nezamzadeh-Ejhieh, Alireza
    JOURNAL OF MOLECULAR CATALYSIS A-CHEMICAL, 2016, 411 : 222 - 229
  • [45] AVOIDANCE OF MEFENAMIC-ACID IN EPILEPSY
    PRESCOTT, LF
    BALALIMOOD, M
    CRITCHLEY, JAJH
    PROUDFOOT, AT
    LANCET, 1981, 2 (8243): : 418 - 418
  • [46] MEFENAMIC-ACID - UNDERRATED ANTIRHEUMATIC
    MAVRIKAKIS, ME
    MACLEOD, M
    BUCHANAN, WW
    HERNANDEZ, LA
    RENNIE, JAN
    CURRENT MEDICAL RESEARCH AND OPINION, 1977, 4 (08) : 535 - 539
  • [47] COMA IN MEFENAMIC-ACID POISONING
    GOSSINGER, H
    HRUBY, K
    HAUBENSTOCK, A
    JUNG, M
    ZWERINA, N
    LANCET, 1982, 2 (8294): : 384 - 384
  • [48] Urinary excretion of mefenamic acid and its metabolites including their esterglucuronides in preterm infants undergoing mefenamic acid therapy
    Sato, J
    Kudo, N
    Owada, E
    Ito, K
    Niida, Y
    Umetsu, M
    Kikuta, T
    Ito, K
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 1997, 20 (04) : 443 - 445
  • [49] MEFENAMIC-ACID, IBUPROFEN, AND DYSMENORRHEA
    SMITH, RP
    POWELL, JR
    OBSTETRICS AND GYNECOLOGY, 1984, 63 (06): : 867 - 867
  • [50] STEATORRHEA COMPLICATING THERAPY WITH MEFENAMIC ACID
    MARKS, JS
    GLEESON, MH
    BRITISH MEDICAL JOURNAL, 1975, 4 (5994): : 442 - 442